Primary structure of somatomedin B: a growth hormone-dependent serum factor with protease inhibiting activity

Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertility.

Endocrine·2010

The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.

The Journal of clinical endocrinology and metabolism·2008

GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.

Clinical endocrinology·2007

The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.

The Journal of clinical endocrinology and metabolism·2006

Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.

Drug metabolism and disposition: the biological fate of chemicals·2004

Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2003

The heterodimeric amino acid transporters (HAT) of the SLC7/SLC3 family: A structure-function relationships and relevance to human pathology.

FEBS letters·2026

Smaller is better: nanobodies meet NMR.

FEBS letters·2026

Membrane composition and thermodynamic identity as boundaries of life for synthetic cell research.

FEBS letters·2026

Characterizing two nanobodies for SMAD4.

FEBS letters·2026

Structural and biochemical analysis of a B12 superbinder.

FEBS letters·2026

BRCA1-mediated transcriptional repression of FABP3 - Implications for breast cancer progression and chemosensitivity.

FEBS letters·2026

Structure-Activity Relationships and Rational Engineering of Plant Defense and Toxic Peptides.

Journal of peptide science : an official publication of the European Peptide Society·2026

Conformational Dynamics of Viral Protease Precursors in Maturation, Inhibition, and Drug-Resistance Development.

Viruses·2026

Salcaprozate Sodium as a Permeation Enhancer-Mechanism, Applications and Unresolved Questions.

Pharmaceutics·2026

Exploring the Anti-Inflammatory Potential of Saudi Propolis Through Phytochemical Characterization, Molecular Docking, and Dynamic Simulation.

Pharmaceutics·2026

Total Synthesis of Xentrivalpeptide A and Its 6α-epi Derivative.

Molecules (Basel, Switzerland)·2026

Ginsenoside Rg2 from Panax spp.: Diverse Biological Activities, Mechanisms and Prospect.

Molecules (Basel, Switzerland)·2026

Related Experiment Videos

Primary structure of somatomedin B: a growth hormone-dependent serum factor with protease inhibiting activity

Related Concept Videos

Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertility.

The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.

GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.

The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.

Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.

Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood.

The heterodimeric amino acid transporters (HAT) of the SLC7/SLC3 family: A structure-function relationships and relevance to human pathology.

Smaller is better: nanobodies meet NMR.

Membrane composition and thermodynamic identity as boundaries of life for synthetic cell research.

Characterizing two nanobodies for SMAD4.

Structural and biochemical analysis of a B12 superbinder.

BRCA1-mediated transcriptional repression of FABP3 - Implications for breast cancer progression and chemosensitivity.

Structure-Activity Relationships and Rational Engineering of Plant Defense and Toxic Peptides.

Conformational Dynamics of Viral Protease Precursors in Maturation, Inhibition, and Drug-Resistance Development.

Salcaprozate Sodium as a Permeation Enhancer-Mechanism, Applications and Unresolved Questions.

Exploring the Anti-Inflammatory Potential of Saudi Propolis Through Phytochemical Characterization, Molecular Docking, and Dynamic Simulation.

Total Synthesis of Xentrivalpeptide A and Its 6α-epi Derivative.

Ginsenoside Rg2 from Panax spp.: Diverse Biological Activities, Mechanisms and Prospect.

Related Experiment Videos

Primary structure of somatomedin B: a growth hormone-dependent serum factor with protease inhibiting activity

Related Concept Videos

Related Articles